Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | increases expression | ISO | Rab17 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of RAB17 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of RAB17 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAB17 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Rab17 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RAB17 mRNA | CTD | PMID:15034205 and PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Rab17 (Mus musculus) | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of RAB17 mRNA] | CTD | PMID:15034205 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RAB17 mRNA | CTD | PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rab17 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAB17 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RAB17 mRNA | CTD | PMID:21215274 | 4-hydroxyphenyl retinamide | increases expression | ISO | Rab17 (Mus musculus) | 6480464 | Fenretinide results in increased expression of RAB17 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of RAB17 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of RAB17 mRNA | CTD | PMID:31881176 | aflatoxin B1 | affects expression | ISO | RAB17 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of RAB17 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of RAB17 mRNA | CTD | PMID:27153756 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of RAB17 mRNA | CTD | PMID:30047161 | antirheumatic drug | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of RAB17 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of RAB17 mRNA | CTD | PMID:33212167 | arsenous acid | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RAB17 protein] | CTD | PMID:26598702 | benzene | increases expression | ISO | Rab17 (Mus musculus) | 6480464 | Benzene results in increased expression of RAB17 and Benzene results in increased expression of RAB17 mRNA | CTD | PMID:12928149 and PMID:15935813 | benzene | multiple interactions | ISO | Rab17 (Mus musculus) | 6480464 | TRP53 protein promotes the reaction [Benzene results in increased expression of RAB17] | CTD | PMID:15935813 | benzo[a]pyrene | decreases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of RAB17 mRNA | CTD | PMID:20106945 and PMID:32234424 | benzo[a]pyrene | affects methylation | ISO | RAB17 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of RAB17 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | RAB17 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of RAB17 exon | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | Rab17 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of RAB17 mRNA | CTD | PMID:15034205 and PMID:22228805 | benzo[a]pyrene | multiple interactions | ISO | Rab17 (Mus musculus) | 6480464 | AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of RAB17 mRNA] | CTD | PMID:15034205 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RAB17 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Rab17 (Mus musculus) | 6480464 | bisphenol A results in increased expression of RAB17 mRNA | CTD | PMID:32156529 more ... | bisphenol A | affects expression | ISO | RAB17 (Homo sapiens) | 6480464 | bisphenol A affects the expression of RAB17 mRNA | CTD | PMID:30903817 | buspirone | increases expression | EXP | | 6480464 | Buspirone results in increased expression of RAB17 mRNA | CTD | PMID:24136188 | calcitriol | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of RAB17 mRNA | CTD | PMID:26485663 | carbamazepine | affects expression | ISO | RAB17 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of RAB17 mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | Rab17 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RAB17 gene] | CTD | PMID:28238834 | chlordecone | increases expression | ISO | Rab17 (Mus musculus) | 6480464 | Chlordecone results in increased expression of RAB17 mRNA | CTD | PMID:33711761 | chromium(6+) | affects expression | ISO | Rab17 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of RAB17 mRNA | CTD | PMID:28472532 | copper(II) sulfate | decreases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of RAB17 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | Rab17 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of RAB17 mRNA | CTD | PMID:19770486 | cyclosporin A | decreases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of RAB17 mRNA | CTD | PMID:20106945 more ... | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of RAB17 mRNA | CTD | PMID:23914054 | diarsenic trioxide | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RAB17 protein] | CTD | PMID:26598702 | dicrotophos | decreases expression | ISO | RAB17 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of RAB17 mRNA | CTD | PMID:28302478 | dioxygen | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of RAB17 mRNA | CTD | PMID:24236059 | dorsomorphin | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of RAB17 mRNA | CTD | PMID:30031762 | entinostat | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | entinostat results in increased expression of RAB17 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB17 mRNA | CTD | PMID:27188386 | etoposide | affects response to substance | ISO | RAB17 (Homo sapiens) | 6480464 | RAB17 protein affects the susceptibility to Etoposide | CTD | PMID:16217747 | fenthion | increases expression | ISO | Rab17 (Mus musculus) | 6480464 | Fenthion results in increased expression of RAB17 mRNA | CTD | PMID:34813904 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of RAB17 mRNA | CTD | PMID:24136188 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of RAB17 mRNA | CTD | PMID:24136188 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of RAB17 mRNA | CTD | PMID:22061828 | mercury dibromide | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of RAB17 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB17 mRNA | CTD | PMID:27188386 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of RAB17 mRNA | CTD | PMID:30047161 | mitomycin C | affects response to substance | ISO | RAB17 (Homo sapiens) | 6480464 | RAB17 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 | p-chloromercuribenzoic acid | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB17 mRNA | CTD | PMID:27188386 | panobinostat | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB17 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | panobinostat results in increased expression of RAB17 mRNA | CTD | PMID:26272509 | paracetamol | decreases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of RAB17 mRNA | CTD | PMID:29067470 | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of RAB17 mRNA | CTD | PMID:30047161 | phenylmercury acetate | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of RAB17 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB17 mRNA | CTD | PMID:27188386 | propiconazole | decreases expression | ISO | Rab17 (Mus musculus) | 6480464 | propiconazole results in decreased expression of RAB17 mRNA | CTD | PMID:21278054 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of RAB17 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of RAB17 mRNA | CTD | PMID:25895662 | sodium arsenite | affects methylation | ISO | RAB17 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of RAB17 gene | CTD | PMID:28589171 | sodium arsenite | decreases expression | ISO | Rab17 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of RAB17 mRNA | CTD | PMID:37682722 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of RAB17 mRNA | CTD | PMID:30047161 | tanespimycin | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [tanespimycin co-treated with VER 155008] results in increased expression of RAB17 protein | CTD | PMID:31370342 | tetrachloromethane | decreases expression | ISO | Rab17 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of RAB17 mRNA | CTD | PMID:31919559 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of RAB17 mRNA | CTD | PMID:23411599 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of RAB17 gene | CTD | PMID:27618143 | tris(2-butoxyethyl) phosphate | decreases expression | ISO | RAB17 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate results in decreased expression of RAB17 mRNA | CTD | PMID:29024780 | valproic acid | increases methylation | ISO | RAB17 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of RAB17 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB17 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | RAB17 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of RAB17 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | RAB17 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RAB17 mRNA | CTD | PMID:25979313 | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of RAB17 gene | CTD | PMID:31079544 | XL147 | multiple interactions | ISO | Rab17 (Mus musculus) | 6480464 | XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB17 mRNA] | CTD | PMID:29891994 | zidovudine | multiple interactions | ISO | RAB17 (Homo sapiens) | 6480464 | [Zidovudine co-treated with IFNA1 protein] results in decreased expression of RAB17 mRNA | CTD | PMID:20370541 | |